» Authors » J Guitard

J Guitard

Explore the profile of J Guitard including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 103
Citations 491
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Guitard J, Bellanger A, Dorin J, Cassaing S, Capitaine A, Gabriel F, et al.
J Mycol Med . 2024 Jun; 34(3):101490. PMID: 38852225
Due to large outbreaks observed worldwide, Candida auris has emerged as a major threat to healthcare facilities. To prevent these phenomena, a systematic screening should be performed in patients transferred...
2.
Rochard C, Bigot J, Balloy V, Hennequin C, Guitard J
Rev Mal Respir . 2024 Mar; 41(4):283-288. PMID: 38458868
Aspergillus fumigatus is the predominant fungal species causing pulmonary aspergillosis. The present-day anti-aspergillosis arsenal is limited, with a number of molecules occasioning severe side effects (amphotericin B) or provoking significant...
3.
Godmer A, Bigot J, Giai Gianetto Q, Benzerara Y, Veziris N, Aubry A, et al.
Sci Rep . 2022 Sep; 12(1):16445. PMID: 36180590
This study aimed to evaluate the contribution of Machine Learning (ML) approach in the interpretation of intercalating dye-based quantitative PCR (IDqPCR) signals applied to the diagnosis of mucormycosis. The ML-based...
4.
Imbert S, Normand A, Cassaing S, Gabriel F, Kristensen L, Bonnal C, et al.
Antimicrob Agents Chemother . 2020 Sep; 64(12). PMID: 32900686
The antifungal susceptibility of cryptic species is poorly known. We assessed 51 isolates, belonging to seven cryptic species, by the EUCAST reference method and the concentration gradient strip (CGS) method....
5.
Bellanger A, Persat F, Foulet F, Bonnal C, Accoceberry I, Angebault C, et al.
J Mycol Med . 2020 Apr; 30(2):100970. PMID: 32334948
A survey of mycology laboratories for antifungal susceptibility testing (AFST) was undertaken in France in 2018, to better understand the difference in practices between the participating centers and to identify...
6.
Delliere S, Verdurme L, Bigot J, Dannaoui E, Senghor Y, Botterel F, et al.
Antimicrob Agents Chemother . 2019 Dec; 64(3). PMID: 31844011
Reference methods used to assess the drug susceptibilities of isolates consisted of EUCAST and CLSI standardized broth microdilution techniques. Considering the increasing rate and the potential impact on the clinical...
7.
Broutin A, Bigot J, Senghor Y, Moreno-Sabater A, Guitard J, Hennequin C
Antimicrob Agents Chemother . 2019 Nov; 64(2). PMID: 31767726
To evaluate the susceptibility of to isavuconazole, 75 clinical isolates were identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry and then tested with a broth microdilution method (EUCAST)...
8.
Imbert S, Normand A, Ranque S, Costa J, Guitard J, Accoceberry I, et al.
Antimicrob Agents Chemother . 2018 Feb; 62(5). PMID: 29439956
section is a species complex currently comprised of 14 cryptic species whose prevalence in clinical samples as well as antifungal susceptibility are poorly known. The aims of this study were...
9.
Guitard J, Isnard F, Tabone M, Antignac M, Brissot E, Senghor Y, et al.
J Infect . 2018 Feb; 76(5):483-488. PMID: 29432826
Objectives: Definitive diagnosis of invasive candidiasis (IC) may be difficult to achieve in patients with haematological malignancy (PHM). We aimed to evaluate the performance of BDG for the diagnosis and...
10.
Senghor Y, Guitard J, Angoulvant A, Hennequin C
Med Mycol . 2017 Nov; 56(6):774-777. PMID: 29087508
Cryptococcal antigen (CryAg) testing in serum and CSF is a clue diagnostic tool for cryptococcosis. In this study, we reviewed the performances of the CryAg detection (Premier EIA, Meridian) routinely...